Skip to main content
OpenTrials

Clinical trial condition

Joint Diseases

Explore clinical trials studying Joint Diseases. Study availability and eligibility vary by location and protocol.

10,310 public trials 1,271 recruiting studies
Refine in advanced search Browse all conditions

Joint Diseases trial results

Completed

A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the Knee

NCT01554579

Conditions
Arthritis, Joint Diseases, Musculoskeletal Diseases, +4 more
Locations
  • Afferent Investigative Site Phoenix, Arizona, United States
  • Afferent Investigative Site Phoenix, Arizona, United States
  • Afferent Investigative Site San Diego, California, United States
  • Afferent Investigative Site Clearwater, Florida, United States
View all 34 locations
View Trial Details
Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

NCT02115750

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Elite Clinical Studies Phoenix, Arizona, United States
  • Arizona Research Center Phoenix, Arizona, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Dream Team Clinical Research Anaheim, California, United States
View all 141 locations
View Trial Details
Completed

Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

NCT02709486

Conditions
Arthritis, Joint Diseases, Musculoskeletal Diseases, +8 more
Locations
  • Nuhr Medical Center Senftenberg, Austria
  • Rheuma Zentrum Favoriten Vienna, Austria
  • Medical Center BLAGOEVGRAD 2009, EOOD Blagoevgrad, Bulgaria
  • DCC St. Pantaleimon OOD Pleven, Bulgaria
View all 148 locations
View Trial Details
Completed

Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis

NCT03028467

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
View all 32 locations
View Trial Details
Completed

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

NCT02198651

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +8 more
Locations
  • J Michael Grelier Research /ID# 149772 Tuscaloosa, Alabama, United States
  • Westlake Medical Research (WMR) Clinical Trials /ID# 155386 Thousand Oaks, California, United States
  • University of Florida /ID# 144851 Jacksonville, Florida, United States
  • North Georgia Rheumatology Grp /ID# 155225 Lawrenceville, Georgia, United States
View all 70 locations
View Trial Details

Related conditions